Investigating new treatments for lung cancer in veterans
Official title: BLRD Research Career Scientist Award Application
Funded at VA Veterans Administration Hospital · NIH-11105896 · Data updated 2026-11-12
This study is looking to find better treatments for veterans with non-small cell lung cancer, especially those who have been exposed to harmful substances like Agent Orange and Asbestos, to help improve their health and well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Veterans Administration Hospital NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project start | April 1, 2019 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| NIH project number | 5IK6BX004603-08 |
| Project ID | NIH-11105896 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include veterans diagnosed with non-small cell lung cancer, particularly those with a history of tobacco use or exposure to carcinogenic agents during military service.
✕Less likely to help
Patients who do not have lung cancer or are not veterans may not receive any benefit from this research.
What this research studies
This research focuses on improving treatment options for non-small cell lung cancer (NSCLC) among veterans, particularly those with a history of exposure to harmful substances like Agent Orange and Asbestos. The study aims to develop therapeutic molecular targeting strategies to enhance patient outcomes, especially for the aging veteran population that is at high risk for lung cancer. By analyzing the unique challenges faced by veterans, the research seeks to address the significant healthcare burden posed by cancer within the Veterans Health Administration system.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for lung cancer, significantly improving survival rates and quality of life for veterans.
How similar studies have gone: Previous research has shown promise in developing targeted therapies for lung cancer, indicating that this approach could yield significant advancements in treatment.
Where this research is happening
-
VA Veterans Administration Hospital
Richmond, United States Active
Researchers
- Principal investigator: Chalfant, Charles E. — VA Veterans Administration Hospital
- Study coordinator: Chalfant, Charles E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.